Products in Subscription
 
Credit Suisse Structured Produts - Room for your development
 

New Issues, January 14, 2013

We are pleased to send you below an overview of our structured products currently in subscription. The Termsheets and additional product information can be accessed by visiting our webpage www.credit-suisse.com/derivatives.
Please enter the respective valor number in order to find the products.
The subscriptions for products can be placed with the client advisor of your bank or directly via phone under +41 (0) 44 335 76 09 *.

Thank you very much for your confidence.

Sincerely yours

Your Structured Retail Products Team

 
Questions & Contacts
Credit Suisse AG
Equity Derivatives Sales (XIDA)
CH-8070 Zurich
Switzerland

For further information contact us at:
Tel. +41 (0) 44 335 76 09 *


Structured Products do not constitute a participation in a collective investment scheme within the meaning of the Swiss Federal Act on Collective Investment Schemes (CISA) and are therefore not subject to authorization and supervision by the Swiss Financial Market Supervisory Authority (FINMA). Investors are not protected by CISA.


New Products in Subscription
Yield Enhancement
  Description SSPA Code Issuer Underlying Ccy Issue Price Coupon/ Max Yld Barrier Feature Maturity Valor End of Subscription

8.25% on Schneider Electric / AXA / SAP 1230 Credit Suisse AG, London Branch Schneider Electric / AXA / SAP EUR 100% 8.25% 59%   24.01.2014
(1yr)
20214519 21.01.2013
(7 days left)

8.25% on Rieter / Sulzer / Lonza 1230 Credit Suisse AG, London Branch Rieter / Sulzer / Lonza CHF 100% 8.25% 69%   24.01.2014
(1yr)
20214520 21.01.2013
(7 days left)

6.75% p.a. on Novartis / Zurich / Roche 1230 Credit Suisse AG, London Branch Novartis / Zurich / Roche CHF 100% 6.75% 69%   24.07.2014
(1.5yrs)
20214518 21.01.2013
(7 days left)
Participation
  Description SSPA Code Issuer Underlying Ccy Issue Price Part. Bonus Level Barrier Maturity Valor End of Subscription

Outperfermance Certificate Zurich 1310 Credit Suisse AG, Zurich Zurich CHF 400%     31.05.2013
(0.3yrs)
19920206 24.01.2013
(10 days left)

Outperfermance Certificate Swiss Re 1310 Credit Suisse AG, Zurich Swiss Re CHF 200%     31.05.2013
(0.3yrs)
19920208 24.01.2013
(10 days left)

Outperfermance Certificate Novartis 1310 Credit Suisse AG, Zurich Novartis CHF 230%     31.05.2013
(0.3yrs)
19920207 24.01.2013
(10 days left)


Other Products in Subscription
Yield Enhancement
  Description SSPA Code Issuer Underlying Ccy Issue Price Coupon/ Max Yld Barrier Feature Maturity Valor End of Subscription

8.00% p.a. on Multi Shares 1220 Credit Suisse International, London JPMorgan Chase / Halliburton / Apple USD 100% 8%   Trigger 30.07.2014
(1.5yrs)
20260573 23.01.2013
(9 days left)

8.00% p.a. on BRIC Indices 1230 Credit Suisse International, London iShares MSCI Brazil / Russian Depositary / DBIX India / Hang Seng China Enterprise USD 100% 8% 55% Callable 29.07.2014
(1.5yrs)
20260571 22.01.2013
(8 days left)

5.20% p.a. on Gold / Silver / Palladium / Platinum 1230 Credit Suisse International, London Gold / Silver / Palladium / Platinum CHF 100% 5.2% 59%   30.01.2015
(2yrs)
20260575 22.01.2013
(8 days left)

6.50% p.a. on Gold / Silver / Palladium / Platinum 1230 Credit Suisse International, London Gold / Silver / Palladium / Platinum USD 100% 6.5% 59%   30.01.2015
(2yrs)
20260576 22.01.2013
(8 days left)

8.00% on Rio Tinto / BHP Billiton / Vale 1230 Credit Suisse AG, London Branch Rio Tinto / BHP Billiton / Vale CHF 100% 8% 65%   23.01.2014
(1yr)
20214516 18.01.2013
(4 days left)

8.00% on Citigroup / Bank of America / Goldman Sachs 1230 Credit Suisse AG, London Branch Citigroup / Bank of America / Goldman Sachs USD 100% 8% 59%   24.01.2014
(1yr)
20214515 18.01.2013
(4 days left)

7.50% p.a. on Syngenta / Monsanto / Potash 1230 Credit Suisse AG, London Branch Syngenta / Monsanto / Potash CHF 100% 7.5% 69%   23.07.2014
(1.5yrs)
20214517 18.01.2013
(4 days left)

7.25% p.a. on Holcim / Swiss Re / ABB 1230 Credit Suisse AG, London Branch Holcim / Swiss Re / ABB CHF 100% 7.25% 65%   22.07.2014
(1.5yrs)
19279633 17.01.2013
(3 days left)

6.50% p.a. on Nestlé / Swatch / Swiss Re 1230 Credit Suisse AG, London Branch Nestlé / Swatch / Swiss Re CHF 100% 6.5% 59%   22.01.2015
(2yrs)
20214513 17.01.2013
(3 days left)

7.25% on Royal Dutch Shell / Unilever / Daimler 1230 Credit Suisse AG, London Branch Royal Dutch Shell / Unilever / Daimler EUR 100% 7.25% 69%   22.01.2014
(1yr)
20214514 17.01.2013
(3 days left)

7.75% on Tiffany & Co. / Ralph Lauren / LVMH 1230 Credit Suisse AG, London Branch Tiffany & Co. / Ralph Lauren / LVMH USD 100% 7.75% 59%   23.01.2014
(1yr)
19279632 17.01.2013
(3 days left)

8.10% p.a. on Brent Crude Oil 1230 Credit Suisse International, London Brent Crude Oil USD 100% 8.1% 75% Callable 24.07.2013
(0.5yrs)
20260572 17.01.2013
(3 days left)

7.25% on Credit Suisse Group 1230 Credit Suisse AG, London Branch Credit Suisse Group CHF 100% 7.25% 69%   21.01.2014
(1yr)
19279629 16.01.2013
(2 days left)

8.00% p.a. on Syngenta / Holcim / Richemont 1230 Credit Suisse AG, London Branch Syngenta / Holcim / Richemont CHF 100% 8% 69%   21.07.2014
(1.5yrs)
19279630 16.01.2013
(2 days left)

7.40% p.a. on SMI® / EURO STOXX 50® / S&P 500® / Nikkei 1230 Credit Suisse AG, London Branch SMI® / EURO STOXX 50® / S&P 500® / Nikkei USD 100% 7.4% 60% Callable 26.01.2015
(2yrs)
19036663 16.01.2013
(2 days left)

6.30% p.a. on SMI® / EURO STOXX 50® / S&P 500® / Nikkei 1230 Credit Suisse AG, London Branch SMI® / EURO STOXX 50® / S&P 500® / Nikkei EUR 100% 6.3% 60% Callable 26.01.2015
(2yrs)
19036662 16.01.2013
(2 days left)

6.25% p.a. on SMI® / EURO STOXX 50® / S&P 500® / Nikkei 1230 Credit Suisse AG, London Branch SMI® / EURO STOXX 50® / S&P 500® / Nikkei CHF 100% 6.25% 60% Callable 26.01.2015
(2yrs)
19036661 16.01.2013
(2 days left)

6.25% p.a. on Novartis / Bayer / Merck & Co. 1230 Credit Suisse AG, London Branch Novartis / Bayer / Merck & Co. CHF 100% 6.25% 65%   21.07.2014
(1.5yrs)
19279628 16.01.2013
(2 days left)

5.50% on Nestlé / Roche / Novartis 1230 Credit Suisse AG, London Branch Nestlé / Roche / Novartis CHF 100% 5.5% 79%   20.01.2014
(1yr)
19279627 15.01.2013
(1 day left)

7.25% on Caterpillar / Deere & Co / General Electric 1230 Credit Suisse AG, London Branch Caterpillar / Deere & Co / General Electric USD 100% 7.25% 65%   21.01.2014
(1yr)
19279626 15.01.2013
(1 day left)

8.50% p.a. on Bayer / Siemens / BMW 1230 Credit Suisse AG, London Branch Bayer / Siemens / BMW EUR 100% 8.5% 65%   17.07.2014
(1.5yrs)
19279625 14.01.2013
(today)

All terms and conditions mentioned in this document are indicative only and will be confirmed or adjusted on the Initial Fixing Date.

Legend

 
CS Product issued by Credit Suisse
New Product added to the list today
Ccy: Currency in which the product is traded
Coupon / Max Yld: Interest paid p.a. / maximum yield achievable for products issued at a discount
Feature: Specific product charateristics
Max Cpn: maximum interest achievable per observation period
Part.: Percentage participation in the performance of the Underlying
Prot. Level: Minimum redemption amount paid by the Issuer
SSPA-Code: Product Category according to Swiss Structured Products Association (http://www.svsp-verband.ch)

 
This message may contain confidential, proprietary or legally privileged information and is intended only for the use of the addressee named above. No confidentiality or privilege is waived or lost by any misstransmission. If you are not the intended recipient of this message you are hereby notified that you must not use, disseminate, copy it in any form or take any action in reliance on it. If you have received this message in error please delete it and any copies of it and notify the sender immediately. Credit Suisse Group AG and its subsidiaries reserve the right to retain, intercept and monitor any e-mail communication through its networks if legally allowed.

This document was produced by Credit Suisse AG and/or its affiliates (hereafter "CS") with the greatest of care and to the best of its knowledge and belief. Credit Suisse provides no guarantee with regard to its content and completeness and does not accept any liability for losses which might arise from making use of this information.

This document does not constitute an offer or a recommendation to buy or sell financial instruments or banking services; the relevant terms and conditions are described in the sales prospectus and summarized in the simplified prospectus in accordance with CISA. We recommend to request prior to an investment decision the complete product information, especially with respect to product specific risks, prices and fees or charges. The product information can be obtained free of charge under the telephone number mentioned herein. The prospectus requirements of Art. 652a / Art. 1156 of the Swiss Code of Obligations are not applicable.

Structured products are suitable only for investors who understand how they work and, in particular, the associated risks, and who are able to bear their financial consequences. Investors are exposed to issuer risk. The structured product's retention of value is dependent not only on the development of the value of the underlying asset, but also on the creditworthiness of the Issuer, which may change over the term of the structured product.

These structured products may include investments in indices:
The underlying indices are registered trademarks and have been licensed for use (SIX Swiss Exchange as licensor for Swiss Market Index (SMI)®; McGraw-Hill Companies Inc. as licensor for S&P 500® Index; STOXX Limited Zurich as licensor for EURO STOXX 50® Index; Nikkei Inc. as licensor for Nikkei 225® Index; Deutsche Börse AG as licensor for DAX® Index and Euronext Paris S.A. as licensor for CAC 40® Index). The indices are compiled and calculated solely by licensors and the licensors shall have no liability with respect thereto. The products based on the indices are in no way sponsored, endorsed, sold or promoted by the licensors.

These structured products may include investments in Emerging Markets:
Emerging Markets are located in countries that possess one or more of the following characteristics: A certain degree of political instability, relatively unpredictable financial markets and economic growth patterns, a financial market that is still at the development stage or a weak economy. Emerging markets investments usually result in higher risks such as political risks, economical risks, credit risks, exchange rate risks, market liquidity risks, legal risks, settlement risks, market risks, shareholder risk and creditor risk.

These structured products may include investments in commodities:
Commodity investments are subject to greater fluctuations in value than normal investments and may lead to additional investment risks.

Neither the information provided on this website may not be sent, taken into or distributed in the United States or to any U. S. person (within the meaning of Regulation S under the US Securities Act of 1933, as amended). This document may not be reproduced either in part or in full without the written permission of Credit Suisse.

*We would like to draw your attention to the fact that telephone calls to our lines are recorded. When we receive your call, we assume that you accept this business practice.

Copyright © 2013 Credit Suisse Group AG and/or its affiliates. All rights reserved.